Fig. 1.
CCR6 expression on CD34+ BM-derived hematopoietic stem cells.
Enriched (> 90% purity) CD34+ BM-derived hematopoietic stem cells were obtained as described in “Materials and methods.” Cells expressing CCR6 and/or CD34 were identified by 2-parameter immunofluorescence analysis using PE-labeled anti-CCR6 (A) or control IgG1 (B) MoAbs and FITC-labeled CD34 MoAb. Percentages of double-positive cells are indicated. One representative donor of the 5 tested is shown.
